A review of the clinical safety
and tolerability of nomifensine
by
Stonier PD
J Clin Psychiatry 1984 Apr; 45(4 Pt 2):89-95

ABSTRACT

The tolerability and safety of nomifensine in clinical practice are reviewed in the context of relevant topics for the second-generation antidepressants. Nomifensine is nonsedating and impairs neither psychomotor nor cognitive performance. It has minimal anticholinergic-like properties and is nontoxic to the heart and cardiovascular system at therapeutic dosage. It is nonepileptogenic. There are few relevant drug interactions, and overdose data to date show no serious sequelae resulting from the drug itself. Side effects include sleep disturbance, restlessness, and nausea; rare adverse reactions are in keeping with other antidepressants. Nomifensine's profile differentiates it from other commonly used antidepressants; the implications of this for treatment of both common depressions and specific at-risk patients are discussed.

Dopamine
Bupropion
Amineptine
Nomifensine: profile
Nomifensine dependence
Nomifensine versus impipramine
Nomifensine, bupropion and cocaine
Nomifensine and haemolytic anaemia

Refs
and further reading

HOME
HedWeb
Nootropics
cocaine.wiki
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family